Trending...
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
TEMECULA, Calif. - ncarol.com -- NATCO proudly announces that the United States Patent and Trademark Office (USPTO) has officially granted U.S. Patent No. 12,453,363 B2 for its latest invention, Persimonal®, a proprietary technology for preparing persimmon leaf extract.
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.
Key Highlights of Persimonal®
Executive Statement
More on ncarol.com
"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."
About NATCO
NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.
www.natcohealthyliving.com
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.
Key Highlights of Persimonal®
- Patent Protection: U.S. Patent No. 12,453,363 B2 secures NATCO's proprietary process for preparing persimmon leaf extract.
- Scientific Innovation: Persimonal® optimizes extraction to preserve and enhance the potency of polyphenols, flavonoids, and other beneficial compounds.
- Health Potential: Persimmon leaf extract has been studied for supporting vascular health, lowering blood pressure and cholesterol, metabolic balance, and overall wellness.
- Market Differentiation: Persimonal® positions NATCO at the forefront of botanical innovation, offering a unique, patent-backed ingredient for nutraceutical and functional food applications.
Executive Statement
More on ncarol.com
- Interview: Why I Sponsored Carson Ware - The Full Story
- March Is Skiing's Smartest Buying Window
- Zeo Health Introduces KidZ Cleanse with Folinic Acid
- Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
- Tobu Group's "T-home Series" of Accommodations in Tokyo Just Opened "T-home KEI."
"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."
About NATCO
NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.
www.natcohealthyliving.com
Source: NATCO, Inc
0 Comments
Latest on ncarol.com
- CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
- Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
- At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
- Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
- VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
- Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
- FPTower Inc. nonprofit launches coastal safety raffle fundraiser
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- STEM Agent Academy Mission 01: Reclaiming Children's Curiosity from the Digital Void
- Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
- Primeindexer Google indexing platform launched by SEO Danmark APS
- Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
- Talentica Announces Winners of Multi-Agent Hackathon 2026
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
- 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
- Husband and Wife Release Children's Book and Donate Proceeds to Non-Profit
